BioRegenx, Inc.
BRGX
$0.01
$0.0013.92%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -24.06% | 13.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -24.06% | 13.86% | |||
| Cost of Revenue | -17.81% | -12.94% | |||
| Gross Profit | -25.23% | 20.96% | |||
| SG&A Expenses | 27.48% | -5.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.52% | -6.69% | |||
| Operating Income | -2,378.82% | 92.08% | |||
| Income Before Tax | -1,162.78% | 54.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1,162.78% | 54.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,162.78% | 54.80% | |||
| EBIT | -2,378.82% | 92.08% | |||
| EBITDA | -4,528.21% | 105.58% | |||
| EPS Basic | -1,000.00% | 50.00% | |||
| Normalized Basic EPS | -100.00% | 0.00% | |||
| EPS Diluted | -1,000.00% | 50.00% | |||
| Normalized Diluted EPS | -100.00% | 0.00% | |||
| Average Basic Shares Outstanding | 0.08% | 0.17% | |||
| Average Diluted Shares Outstanding | 0.08% | 0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||